Literature DB >> 2612516

Mephenytoin stereoselective elimination in the rat: I. Enantiomeric disposition following intravenous administration.

S H Akrawi1, P J Wedlund.   

Abstract

The stereoselective disposition of mephenytoin was characterized after an intravenous bolus dose of racemic mephenytoin to rats being infused with 50% polyethylene glycol 400/50% saline via the jugular and hepatic portal vein. No significant influence on mephenytoin disposition was noted due to the site selected for the administration of the 50% polyethylene glycol 400 solution. The mean (+/- SD) clearance of R- and S-mephenytoin were 171 +/- 58 ml/hr (R) and 110 +/- 37 ml/hr (S), and the mean (+/- SD) volumes of distribution were 325 +/- 75 ml (R) and 359 +/- 72 ml (S). The clearance of R-mephenytoin was significantly larger than the clearance of S-mephenytoin, but this stereoselective difference is of opposite stereochemistry and of much smaller magnitude than the stereoselective difference reported for these enantiomers in man. The difference in the volumes of distribution of R- and S-mephenytoin was not significant.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612516     DOI: 10.1007/BF03190099

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  16 in total

1.  Fulminating dermatitis bullosa medicamentosa due to mesantoin.

Authors:  D B RUSKIN
Journal:  J Am Med Assoc       Date:  1948-07-17

2.  Mesantoin in epilepsy; a 3 year study.

Authors:  J L FETTERMAN; V M VICTOROFF
Journal:  Dis Nerv Syst       Date:  1949-12

3.  Effect of stress and sampling site on metabolite concentration in rat plasma.

Authors:  L Arola; A Palou; X Remesar; E Herrera; M Alemany
Journal:  Arch Int Physiol Biochim       Date:  1980-05

4.  Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man.

Authors:  A Küpfer; P V Desmond; S Schenker; R A Branch
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

5.  Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.

Authors:  P J Wedlund; B J Sweetman; C B McAllister; R A Branch; G R Wilkinson
Journal:  J Chromatogr       Date:  1984-04-13

6.  Characterization of antipyrine autoinduction in the rat utilizing a new microsampling technique for serial blood sample collections.

Authors:  S L Chang; K Emmick; P J Wedlund
Journal:  J Pharm Sci       Date:  1986-05       Impact factor: 3.534

7.  Method for chronic portal vein infusion in unrestrained rats.

Authors:  S H Akrawi; P J Wedlund
Journal:  J Pharmacol Methods       Date:  1987-03

8.  Analysis of hydroxylated and demethylated metabolites of mephenytoin in man and laboratory animals using gas-liquid chromatography and high-performance liquid chromatography.

Authors:  A Küpfer; R James; K Carr; R Branch
Journal:  J Chromatogr       Date:  1982-10-08

9.  Clinical pharmacology of mephenytoin and ethotoin.

Authors:  A S Troupin; P Friel; M P Lovely; A J Wilensky
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

10.  Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.

Authors:  P J Wedlund; W S Aslanian; E Jacqz; C B McAllister; R A Branch; G R Wilkinson
Journal:  J Pharmacol Exp Ther       Date:  1985-09       Impact factor: 4.030

View more
  2 in total

1.  Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administration.

Authors:  S H Akrawi; P J Wedlund
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Oct-Dec       Impact factor: 2.441

2.  Mephenytoin stereoselective elimination in the rat: III. Stereoselective time course of induction during chronic hepatic portal vein administration.

Authors:  S H Akrawi; P J Wedlund
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jul-Sep       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.